Table 2.

Comparison of the approaches of proactive PCPs versus non-proactive PCPs in lifestyle treatment/drug treatment / surgical intervention

Variables	Highly proactive PCPs (n = 67)	Less proactive PCPs (n = 78)	P-value
Q2. To which extent do you agree with the following statements?
Lifestyle modification is effective in reducing weight (agree/strongly agree)	56 (81.2%)	63 (82.9%)	0.786
Pharmacological treatment is effective in reducing weight (agree/strongly agree)	62 (81.6%)	37 (53.6%)	< 0.001
Surgical treatment is effective in reducing weight (agree/strongly agree)	54 (71.1%)	42 (60.9%)	0.195
Obesity medication has a high rate of side effects (agree/strongly agree)	20 (26.6%)	16 (23.6)	0.298
Surgical treatment of obesity has significant complications (agree/strongly agree)	12 (15.8%)	6 (8.8%)	0.360
Q7. If you do not tend to offer pharmaceutical treatment to patients, what are the reasons for it?
lack of knowledge	4 (5.3%)	23 (33.3%)	< 0.001
do not know the indication	4 (5.3%)	5 (7.2%)	0.621
	10 (13.2%)	10 (14.5%)	0.816
expensive	11 (14.5%)	12 (17.4%)	0.631
Do not believe in this treatment	8 (10.5%)	11 (15.9%)	0.334
Concern about the side effects	11 (14.5%)	11 (15.9%)	0.806
Unresponsiveness of the patient	13 (17.1%)	9 (13%)	0.496
Q8. How often do you offer these treatments to your patients? (Always or often vs. rarely or almost never)
lifestyle modification	75 (100%)	67 (98.5%)	0.292
pharmacological treatment	49 (65.3%)	19 (28.4%)	< 0.001
surgical treatment	10 (13.7%)	2 (3%)	0.024